IL-22 is secreted by proximal tubule cells and regulates DNA damage response and cell death in acute kidney injury
Kidney International · 2024
DOI: 10.1016/j.kint.2023.09.020 ↗Kurz gefasst
Fachartikel in der Zeitschrift Kidney International, 2024. Verfasst von Kensei Taguchi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Vanderbilt University Medical Center, Nashville, Tennessee, USA. Hauptthemen laut MEDLINE: Cisplatin, Acute Kidney Injury. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NEI NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Acute kidney injury (AKI) affects over 13 million people worldwide annually and is associated with a 4-fold increase in mortality. Our lab and others have shown that DNA damage response (DDR) governs the outcome of AKI in a bimodal manner. Activation of DDR sensor kinases protects against AKI, while hyperactivation of DDR effector proteins, such as p53, induces cell death and worsens AKI. The factors that trigger DDR to switch from pro-repair to pro-cell death remain to be resolved. Here we investigated the role of interleukin 22 (IL-22), an IL-10 family member whose receptor (IL-22RA1) is expressed on proximal tubule cells (PTCs), in DDR activation and AKI. Using cisplatin and aristolochic acid (AA) induced nephropathy as models of DNA damage, we identified PTCs as a novel source of urinary IL-22. Functionally, IL-22 binding IL-22RA1 on PTCs amplified the DDR. Treating primary PTCs with IL-22 alone induced rapid activation of the DDR. The combination of IL-22 and either cisplatin- or AA-induced cell death in primary PTCs, while the same dose of cisplatin or AA alone did not. Global deletion of IL-22 protected against cisplatin- or AA-induced AKI, reduced expression of DDR components, and inhibited PTC cell death. To confirm PTC IL-22 signaling contributed to AKI, we knocked out IL-22RA1 specifically in kidney tubule cells. IL-22RA1ΔTub mice displayed reduced DDR activation, cell death, and kidney injury compared to controls. Thus, targeting IL-22 represents a novel therapeutic approach to prevent the negative consequences of the DDR activation while not interfering with repair of damaged DNA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Nephrology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
- Division of Pharmaceutics and Pharmacology, College of Pharmacy & Comprehensive Cancer Center, Ohio State University, Columbus, Ohio, USA.
- Overgrowth Syndrome and Vascular Anomalies Unit, Hôpital Necker Enfants Malades, Université de Paris, Paris, France.
- Division of Nephrology, Vanderbilt University Medical Center, Nashville, Tennessee, USA; Department of Cell and Developmental Biology, Vanderbilt University, Nashville, Tennessee, USA. Electronic address: Craig.brooks@v…
Förderung
- NIDDK NIH HHS
- NEI NIH HHS
- NCI NIH HHS
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases
- American Heart Association
Zitieren
APA
Taguchi, K., Sugahara, S., Elias, B. C., Pabla, N. S., Canaud, G., & Brooks, C. R. (2024). IL-22 is secreted by proximal tubule cells and regulates DNA damage response and cell death in acute kidney injury. Kidney International. https://doi.org/10.1016/j.kint.2023.09.020
Vancouver
Taguchi K, Sugahara S, Elias BC, Pabla NS, Canaud G, Brooks CR. IL-22 is secreted by proximal tubule cells and regulates DNA damage response and cell death in acute kidney injury. Kidney International. 2024. doi:10.1016/j.kint.2023.09.020
BibTeX
@article{Taguchi2024,
author = {Taguchi, Kensei and Sugahara, Sho and Elias, Bertha C and Pabla, Navjot S and Canaud, Guillaume and Brooks, Craig R},
title = {IL-22 is secreted by proximal tubule cells and regulates DNA damage response and cell death in acute kidney injury},
journal = {Kidney International},
year = {2024},
doi = {10.1016/j.kint.2023.09.020}
}
EUVIMED